Anuh Pharma Limited (BOM:506260)
82.12
-0.87 (-1.05%)
At close: Feb 12, 2026
Anuh Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 195.57 | 72.02 | 19.27 | 37.96 | 21.98 |
Short-Term Investments | - | 15.02 | 12.37 | 8.1 | - | 49.45 |
Trading Asset Securities | - | 523.56 | 538.17 | 503.4 | 214.69 | 60.7 |
Cash & Short-Term Investments | 130.96 | 734.15 | 622.56 | 530.77 | 252.65 | 132.13 |
Cash Growth | -74.78% | 17.93% | 17.29% | 110.08% | 91.21% | -80.48% |
Accounts Receivable | - | 2,159 | 1,899 | 1,712 | 1,357 | 1,069 |
Other Receivables | - | 97.33 | 61.96 | 39.14 | 5.25 | 163.64 |
Receivables | - | 2,261 | 1,968 | 1,756 | 1,370 | 1,242 |
Inventory | - | 744.81 | 754 | 726.36 | 799.23 | 814.26 |
Prepaid Expenses | - | 17.72 | 5.88 | 5.72 | 4.79 | 4.4 |
Restricted Cash | - | - | - | 30.5 | - | - |
Other Current Assets | - | 3.54 | 35.29 | 26.61 | 159.98 | 184.97 |
Total Current Assets | - | 3,762 | 3,385 | 3,076 | 2,587 | 2,377 |
Property, Plant & Equipment | - | 583.65 | 492.42 | 526.76 | 613.41 | 711.83 |
Long-Term Investments | - | 619.55 | 517.14 | 396.84 | 212.13 | 203.71 |
Other Intangible Assets | - | 1.21 | 1.58 | 1.31 | 1.83 | 2.4 |
Long-Term Deferred Tax Assets | - | 20.8 | 4.22 | 7.68 | - | - |
Other Long-Term Assets | - | 77.76 | 53.99 | 41.09 | 57.51 | 31.16 |
Total Assets | - | 5,066 | 4,457 | 4,050 | 3,472 | 3,326 |
Accounts Payable | - | 1,568 | 1,405 | 1,528 | 1,216 | 1,200 |
Accrued Expenses | - | 7.08 | 6.16 | 4.74 | 3.34 | 3.39 |
Short-Term Debt | - | 104.98 | 20.13 | - | 31.11 | 135.98 |
Current Portion of Leases | - | 3.3 | 2.91 | 0.67 | 2.06 | 0.78 |
Current Income Taxes Payable | - | 5.48 | - | - | - | - |
Other Current Liabilities | - | 95.85 | 92.72 | 80.29 | 56.81 | 54.39 |
Total Current Liabilities | - | 1,785 | 1,527 | 1,613 | 1,309 | 1,395 |
Long-Term Leases | - | 0.58 | 3.88 | 8.39 | 9.07 | - |
Pension & Post-Retirement Benefits | - | 12.92 | 11.05 | 9.91 | 9.72 | 9.6 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.48 | 10.14 |
Other Long-Term Liabilities | - | 7.39 | 2.75 | 5.93 | 5.69 | 5.53 |
Total Liabilities | - | 1,806 | 1,545 | 1,638 | 1,334 | 1,420 |
Common Stock | - | 250.56 | 250.56 | 250.56 | 250.56 | 250.56 |
Retained Earnings | - | 3,009 | 2,660 | 2,160 | 1,886 | 1,655 |
Comprehensive Income & Other | - | 1.14 | 1.31 | 1.69 | 1.3 | 0.46 |
Shareholders' Equity | 3,269 | 3,260 | 2,912 | 2,412 | 2,138 | 1,906 |
Total Liabilities & Equity | - | 5,066 | 4,457 | 4,050 | 3,472 | 3,326 |
Total Debt | 2.27 | 108.86 | 26.93 | 9.07 | 42.24 | 136.75 |
Net Cash (Debt) | 128.69 | 625.29 | 595.63 | 521.7 | 210.41 | -4.63 |
Net Cash Growth | -65.97% | 4.98% | 14.17% | 147.94% | - | - |
Net Cash Per Share | 1.28 | 6.24 | 5.94 | 5.21 | 2.10 | -0.05 |
Filing Date Shares Outstanding | 100.38 | 100.22 | 100.22 | 100.22 | 100.22 | 100.22 |
Total Common Shares Outstanding | 100.38 | 100.22 | 100.22 | 100.22 | 100.22 | 100.22 |
Working Capital | - | 1,977 | 1,858 | 1,463 | 1,278 | 982.61 |
Book Value Per Share | 32.64 | 32.53 | 29.06 | 24.07 | 21.33 | 19.02 |
Tangible Book Value | 3,268 | 3,259 | 2,911 | 2,411 | 2,136 | 1,904 |
Tangible Book Value Per Share | 32.63 | 32.52 | 29.04 | 24.06 | 21.31 | 19.00 |
Land | - | 15.59 | 15.59 | 113.07 | 113.07 | 113.07 |
Buildings | - | 146.73 | 146.73 | 146.73 | 146.73 | 146.12 |
Machinery | - | 941.3 | 767.32 | 723.6 | 713.5 | 709.4 |
Construction In Progress | - | 2.71 | 4.54 | - | 1 | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.